최성원

최성원 is a declared insider of 광동제약 (chief executive), with filings sourced from DART (FSS). Over a trading history stretching from 22 April 2021 to 12 October 2026, the count stands at 36 filings.

The open-market side counts 3 purchases alongside 2 sales. The totals do not cover 5 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show no purchases and 1 sale.

Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 12 October 2026 came the latest disclosure, a transaction in 광동제약. The most recent open-market purchase was published on 8 April 2025, 558 days ago. The median gap between a trade and its publication by DART (FSS) is 3 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from DART (FSS). Past trades are no guide to future returns.